webinar
Vascular Nano-Delivery Using Tropism and Targeting
Vladimir R. Muzykantov, MD, PhD | Founding Co-Director, CT3N at UPenn
Register

Azido-PEG3-Val-Cit-PAB-OH

  Cat No.: BADC-01039   Purity: >98.0% 4.5  

Azido-PEG3-Val-Cit-PAB-OH is a cleavable ADC linker with Val-Cit dipeptide and PAB spacer for enzymatic release, combined with azide and PEG3 for hydrophilicity and click chemistry bioconjugation.

Azido-PEG3-Val-Cit-PAB-OH

Structure of 2055024-65-0

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
Cleavable Linker
Molecular Formula
C27H44N8O8
Molecular Weight
608.69
Shipping
-20°C (International: -20°C)
Storage
-20°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
(S)-2-((S)-1-azido-14-isopropyl-12-oxo-3,6,9-trioxa-13-azapentadecan-15-amido)-N-(4-(hydroxymethyl)phenyl)-5-ureidopentanamide
IUPAC Name
Canonical SMILES
CC(C)C(C(=O)NC(CCCNC(=O)N)C(=O)NC1=CC=C(C=C1)CO)NC(=O)CCOCCOCCOCCN=[N+]=[N-]
InChI
InChI=1S/C27H44N8O8/c1-19(2)24(34-23(37)9-12-41-14-16-43-17-15-42-13-11-31-35-29)26(39)33-22(4-3-10-30-27(28)40)25(38)32-21-7-5-20(18-36)6-8-21/h5-8,19,22,24,36H,3-4,9-18H2,1-2H3,(H,32,38)(H,33,39)(H,34,37)(H3,28,30,40)/t22-,24-/m0/s1
InChIKey
UNBTYONTPDVRKD-UPVQGACJSA-N
Solubility
10 mm in DMSO
Appearance
Solid
Shelf Life
-20°C 3 years powder; -80°C 2 years in solvent
Shipping
-20°C (International: -20°C)
Storage
-20°C
Form
Solid

Azido-PEG3-Val-Cit-PAB-OH, a versatile linker molecule extensively utilized in the biosciences, offers a myriad of applications in drug delivery and bioconjugation. Here are four key applications presented with a high degree of perplexity and burstiness:

Antibody-Drug Conjugates (ADCs): Serving as a pivotal component in the synthesis of antibody-drug conjugates, Azido-PEG3-Val-Cit-PAB-OH acts as a cleavable linker that intricately connects the antibody and cytotoxic drug. This intricate design ensures the precise release of the drug within target cells upon internalization, enhancing the specificity and potency of cancer therapies. By minimizing off-target effects and maximizing therapeutic outcomes, this innovative approach revolutionizes the landscape of cancer treatment.

Prodrug Development: Embracing the concept of prodrug development, this versatile linker molecule plays a pivotal role in connecting the active drug molecule to a carrier, thereby enhancing solubility and stability. Upon reaching the desired target site, the linker undergoes cleavage, releasing the active drug and facilitating optimal drug delivery and bioavailability. This strategic approach transforms the field of drug development, fostering more efficacious treatments across various medical conditions.

Targeted Drug Delivery: Taking the lead in targeted drug delivery systems, Azido-PEG3-Val-Cit-PAB-OH contributes to the creation of nanoparticles and liposomes by attaching targeting ligands. This innovative approach enhances the precision of therapeutic delivery to specific cells or tissues, such as tumor sites or inflammatory regions, while simultaneously reducing systemic side effects. By optimizing the delivery mechanism, this cutting-edge technology elevates treatment efficacy and patient outcomes.

Bioconjugation: The presence of the azido group within Azido-PEG3-Val-Cit-PAB-OH facilitates click chemistry-based bioconjugation, a crucial process for attaching biomolecules to surfaces, drug carriers, or other macromolecules. This streamlined approach enables the development of multifunctional biomaterials and advanced diagnostic tools, propelling bioscience research forward. The efficiency and simplicity of bioconjugation techniques streamline experimental procedures, ushering in a new wave of innovative applications in the realm of biochemistry and molecular biology.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: N3Ac-OPhOMe | 4-Pentynoyl-Val-Ala-PAB-PNP | Me-Tet-PEG3-Maleimide | N3-Gly-Gly-Gly-Gly-Gly-OH | Mal-Sulfo-DBCO | m-PEG12-OH | mPEG5-acetic acid | Acid-PEG2-SS-PEG2-acid | H-D-Lys(N3)-OH HCl | Fmoc-NMe-PEG3-acid | Azido-PEG3-Val-Cit-PAB-OH
Send Inquiry
Verification code
Inquiry Basket